Merck Inks Deal on Vaccines
April 22, 2010
Merck & Co. has entered a deal with tiny vaccine maker MassBiologics to distribute its vaccine against tetanus and diphtheria in 49 states, according to the Associated Press. Merck will start distributing the Td vaccine in June throughout the U.S. except for Massachusetts. MassBiologics, a 116-year-old nonprofit vaccine developer now run by the University of Massachusetts Medical School, will continue to distribute the vaccine in that state. Terms of the deal were not disclosed. Tetanus and diphtheria are both bacterial illnesses whose incidence has greatly been reduced by vaccines. The new deal fills a gap in Merck''s extensive vaccine lineup, enabling its sales representatives to encourage doctor loyalty by offering pediatricians and other physicians one-stop shopping for nearly every vaccine they provide to patients.